TDP1: Scientists Identify a promising new target in overcoming cancer treatment

Researchers from IACS Kolkata have identified TDP1 as a potential target for cancer therapy, offering hope for overcoming resistance to existing treatments. By inhibiting TDP1 and CDK1, the new combination therapy could enhance the effectiveness of current cancer drugs and reduce cancer cells’ DNA repair abilities.